Zoledronate

response biomarkers — cross-omics
Drug responseDRUG → SHRNACell lineZoledronic acid, Zometa, Reclast

Across CCLE and GDSC cell-line panels, response to Zoledronate is significantly associated with the shRNA dependency of multiple gene dependencies, with PANCREAS cell lines showing a particularly strong set of associations.

The most reproducible Zoledronate response-associated gene dependencies across cancer lineages are AXIN1, ATP6V0C, and MUC1, each associated with drug response in up to 8 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.

Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Zoledronate response versus AXIN1 shRNA dependency in PANCREAS (Pearson r = 0.63).

Shrna dependency biomarkers of Zoledronate response

Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner gene dependencieX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
PANCREASAXIN1 →+0.361+0.489.016.03938
LUNG_NSCLC_LUSCATP6V0C →+0.466+0.409.034.03937
SKINMUC1 →+0.195+0.198.019.04537
SOFT_TISSUESLC4A8 →+0.183+0.610.003.00637
PANCREASATP6V1H →-0.228-0.430.015.04537
PANCREASB3GALNT1 →+0.238+0.748.006.01737
Each biomarker links to its Q-omics profile. Showing the 6 strongest associations by consensus.

Zoledronate response vs AXIN1 — PANCREAS

Per-cell-line scatter of Zoledronate response vs AXIN1 shRNA dependency in PANCREAS.

Explore this scatter interactively →

Exploration